Zolpidem Tartrate Tablet, Extended Release
Product Images NDC 60760-819

5 FDA label images from St. Mary's Medical Park Pharmacy · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Zolpidem Tartrate (NDC 60760-819). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by St. Mary's Medical Park Pharmacy, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Zolpidem Tartrate (E56668d7 16c2 4618 Ba3b Df3853f307e6 01)

Zolpidem Tartrate (E56668d7 16c2 4618 Ba3b Df3853f307e6 01)
Chemical structure of the active ingredient Zolpidem Tartrate, depicting the molecular arrangement of atoms for this compound used in extended-release tablets.*
FDA Label Image

Im-2 (E56668d7 16c2 4618 Ba3b Df3853f307e6 02)

Im-2 (E56668d7 16c2 4618 Ba3b Df3853f307e6 02)
A pharmacokinetic line graph illustrating zolpidem plasma concentrations (ng/mL) over time (hours) comparing 12.5 mg zolpidem tartrate extended-release tablets and 10 mg immediate-release tablets. The x-axis represents time in hours (0 to 8), and the y-axis shows plasma concentration levels (0 to 120 ng/mL). Data show different absorption and elimination profiles for the two formulations.*
FDA Label Image

Image (39503a0f Bbf2 4bb4 Ab5d 118d2e3b5bbf 304 1)

Image (39503a0f Bbf2 4bb4 Ab5d 118d2e3b5bbf 304 1)
Packaging label of ZOLPIDEM TARTRATE extended release tablets, 12.5 mg strength. The image shows a blister card containing 7 oval tablets arranged in a circular flower-like pattern with one tablet in the center and six surrounding it. The labeler is St. Mary's Medical Park Pharmacy.*
FDA Label Image

Image (39503a0f Bbf2 4bb4 Ab5d 118d2e3b5bbf 334 1)

Image (39503a0f Bbf2 4bb4 Ab5d 118d2e3b5bbf 334 1)
ZOLPIDEM TARTRATE 12.5 mg extended release oral tablets in a blister pack. The blister contains ten tablets arranged in two overlapping five-tablet rows. The tablets are round and white, with each cavity sealed individually. No additional text or branding is visible on the blister pack itself.*
FDA Label Image

819 (Zolpidem 60760 819 30)

819 (Zolpidem 60760 819 30)
Label for Zolpidem Tartrate Extended-Release Tablets USP 12.5 mg, quantity 30. The label shows the product name, dosage strength, and extended-release tablet form. It includes the NDC 60760-819-30 and barcodes. The product is manufactured by Lupin Limited, Goa, India, and packaged by St. Mary's Medical Park Pharmacy, Oro Valley, AZ. The label indicates storage instructions for controlled room temperature 15°-30°C and includes usage direction 'Use as directed.' Lot number and expiration date are marked with question marks.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.